Table I.
Characteristic | Females | Males | P |
---|---|---|---|
N=64 % | N=52 % | ||
Age at study | 0.47 | ||
| |||
18–24 y | 59 | 69 | |
25–34 y | 38 | 37 | |
35–37 y | 3 | 4 | |
| |||
Race and ethnicity | 0.11 | ||
| |||
White, Non-Hispanic | 69 | 81 | |
Black, Non-Hispanic | 14 | 8 | |
Hispanic or Latino | 17 | 8 | |
Other | 0 | 4 | |
| |||
Cancer therapy | |||
| |||
Chemotherapy | |||
Anthracycline | 66 | 80 | 0.09 |
Cyclophosphamide | 39 | 46 | 0.45 |
Dexamethasone | 14 | 4 | 0.37 |
Cranial radiotherapy (CRT) | |||
Any CRT | 38 | 29 | 0.42 |
< 24 Gy | 9 | 10 | 0.28 |
≥ 24 Gy | 28 | 19 | 0.41 |
Stem cell transplant | 5 | 8 | 0.70 |
Total body irradiation | 5 | 8 | 0.70 |